NCT06673485

Brief Summary

The aim of the study is to evaluate the effect of Vit D and Calcium administration on allogragt bone maturation radiographically and histomorphometercally in maxillary sinus augmentation in cases of D4 bone density.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 13, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
Last Updated

November 5, 2024

Status Verified

October 1, 2024

Enrollment Period

1.4 years

First QC Date

October 13, 2024

Last Update Submit

November 2, 2024

Conditions

Keywords

maxillary sinus augmentationSinus graftInternal Sinus liftingAllogenic bone graft

Outcome Measures

Primary Outcomes (1)

  • The Implant Stability Quotient

    The Implant Stability Quotient (ISQ) will be assessed using the Osstell device, which provides a stability score ranging from 0 ISQ to 100 ISQ. Higher ISQ values indicate greater implant stability, with 0 ISQ representing the lowest stability and 100 ISQ the highest. This measure allows for consistent, objective assessment of implant stability across time points.

    Immediate post-operative, and 6 Months post-operative

Secondary Outcomes (3)

  • DXA Scan

    pre-operative, and 6 Months post-operative

  • Vitamin D serum levels

    Pre-operative, and 6 Months post-operative

  • Calcium Serum Level

    Pre-operative, and 6 Months post-operative

Study Arms (2)

Group A : Patients received vitamin D and calcium supplementation during the healing period

EXPERIMENTAL

1. Monthly intramuscular injections of vitamin D3 (300,000 I.U.) for three months, concurrent with six months of oral Maxical vitamin D supplementation post-implant placement. 2. Daily intake of Maxical calcium carbonate tablets (600 mg elemental calcium) for six months.

Procedure: Patients received vitamin D and calcium supplementation during the healing period

Group B: Patients have not received any nutritional supplementation during the healing period.

EXPERIMENTAL
Procedure: Patients have not received any nutritional supplementation during the healing period.

Interventions

The proposed implant site and adjacent tissues were disinfected using betadine mouthwash, and standard infiltration anesthesia was administered both buccally and palatally. A paracrestal incision was then made over the intended implant location, and the mucoperiosteal flap was elevated to expose the underlying bone. Subsequently, an osteotomy was prepared using a 2.0 mm pilot drill, maintaining irrigation with sterile saline. The osseodensification protocol was employed with Densah burs in increasing diameters (2 mm, 3 mm, 4 mm) under copious irrigation. Throughout the osteotomy preparation, implant angulation was regularly checked using a paralling pin. Upon encountering haptic feedback, pressure was modulated to achieve the desired depth. The implant was then installed using a surgical handpiece, and the final insertion torque was recorded using a torque wrench, ensuring successful placement. During the healing period, the patients recieved Vitamin D and Calcium Supplements.

Group A : Patients received vitamin D and calcium supplementation during the healing period

The proposed implant site and adjacent tissues were disinfected using betadine mouthwash, and standard infiltration anesthesia was administered both buccally and palatally. A paracrestal incision was then made over the intended implant location, and the mucoperiosteal flap was elevated to expose the underlying bone. Subsequently, an osteotomy was prepared using a 2.0 mm pilot drill while maintaining irrigation with sterile saline. The osseodensification protocol was employed with Densah burs in increasing diameters (2 mm, 3 mm, 4 mm) under copious irrigation. Throughout the osteotomy preparation, implant angulation was regularly checked using a paraling pin. Upon encountering haptic feedback, pressure was modulated to achieve the desired depth. The implant was then installed using a surgical handpiece, and the final insertion torque was recorded using a torque wrench, ensuring successful placement. During the healing period, the patients did not receive vitamin or calcium supplements.

Group B: Patients have not received any nutritional supplementation during the healing period.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with residual bone height from 5 : 8 .
  • Patient with insufficient Vit D levels.
  • Patient with D4 bone density.

You may not qualify if:

  • Patients that have aproporiate amount of Ca and Vit D.
  • Sinus pathology that precludes routine sinus augmentation.
  • Heavy smookers patients.
  • Systemic diseases that interfere with bone maturion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alazhar University

Asyut, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident at Oral and Maxillofacial Surgery

Study Record Dates

First Submitted

October 13, 2024

First Posted

November 5, 2024

Study Start

October 2, 2021

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

November 5, 2024

Record last verified: 2024-10

Locations